TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again May 27, 1988